Aquestive Therapeutics, Inc. (AQST)
After hours:
Chart Events
Performance Outlook
| Previous Close | 0.9800 |
| Open | 1.0000 |
| Bid | 1.0000 x 800 |
| Ask | 1.0300 x 1100 |
| Day's Range | 0.9720 - 1.0400 |
| 52 Week Range | 0.9580 - 6.4000 |
| Volume | |
| Avg. Volume | 390,363 |
| Market Cap | 43.17M |
| Beta (5Y Monthly) | 3.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.7470 |
| Earnings Date | Aug 01, 2022 - Aug 05, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for AQST
Related Research
- Aquestive Therapeutics, Inc.Technical Assessment: Neutral in the Intermediate-TermWe are raising our intermediate-term technical outlook to neutral from bearish. This reverses our April 22 intermediate-term downgrade from neutral to bearish. This action is not a green light and we are not saying the bottom is in and it's up, up, and away from here. But we do think the major indices are attempting to hammer out (via a candlestick pattern) a bottom because we have seen a few "sticks" in recent trading sessions. Simply put, we are seeing days where stocks trade significantly lower but then finish strong.RatingFair ValueEconomic Moat3 days agoArgus Research
- GlobeNewswire
Aquestive Therapeutics Announces CEO Transition
Daniel Barber, current Chief Operating Officer of Aquestive, appointed as President and Chief Executive Officer and member of Board of DirectorsKeith Kendall, President and Chief Executive Officer and member of Board of Directors, will be leaving the CompanyKeith Kendall engaged as consultant to end of year to assist in management transition WARREN, N.J., May 17, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’
- Simply Wall St.
When Will Aquestive Therapeutics, Inc. (NASDAQ:AQST) Become Profitable?
We feel now is a pretty good time to analyse Aquestive Therapeutics, Inc.'s ( NASDAQ:AQST ) business as it appears the...
- GlobeNewswire
Aquestive Therapeutics to Participate in H.C. Wainwright Global Investment Conference
WARREN, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, announced today that the management team will participate in the H.C. Wainwright Global Investment Conference from May 23rd to May 26th. The Aquestive team is scheduled to present on May 25th at 2:30 pm ET and will host investor meetings at the
